F13.95 Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced psychotic disorder

Name of the Condition

• Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced psychotic disorder

Summary

This condition involves the use of sedative, hypnotic, or anxiolytic substances with an associated psychotic disorder induced by these substances. The pattern of use is not specified further, and the psychotic disorder is directly attributed to the effects of the sedative, hypnotic, or anxiolytic drugs. These substances are commonly prescribed for anxiety, insomnia, or sedation but may lead to psychotic symptoms in some individuals.

Causes

The condition arises from the use of sedative, hypnotic, or anxiolytic drugs, such as benzodiazepines or barbiturates. The psychotic disorder is a direct result of the substance's effects on the central nervous system. Use may be prescribed or non-medical, and the unspecified nature indicates insufficient detail to classify the pattern of use beyond the presence of the induced psychotic disorder.

Risk Factors

• Prolonged or excessive use of these medications
• High dosages or frequent administration
• Personal or family history of substance use disorders
• Underlying mental health conditions (e.g., anxiety, depression)
• Easy access to sedative/hypnotic/anxiolytic drugs
• Recreational or non-medical use

Symptoms

• Use of sedative, hypnotic, or anxiolytic substances
• Presence of psychotic symptoms (e.g., delusions, hallucinations) attributed to the substance
• Symptoms not better explained by another mental disorder or medical condition

Diagnosis

Diagnosis is based on clinical evaluation of substance use history and assessment of psychotic symptoms. The psychotic disorder must be directly induced by the sedative, hypnotic, or anxiolytic substance, and the pattern of use is unspecified. The absence of other causes for the psychotic symptoms is key to distinguishing this condition.

Treatment Options

• Discontinuation or reduction of the sedative, hypnotic, or anxiolytic substance
• Management of psychotic symptoms (e.g., antipsychotic medications)
• Monitoring for substance withdrawal or dependence
• Addressing underlying substance use patterns
• Psychiatric evaluation and support

Prognosis and Follow-Up

Prognosis depends on the severity of the psychotic disorder and the individual's response to treatment. Follow-up is important to monitor for recurrence of psychotic symptoms, substance use patterns, and potential complications. Long-term management may involve ongoing psychiatric care and substance use support.

Complications

• Worsening of psychotic symptoms
• Substance dependence or withdrawal
• Impaired cognitive function
• Increased risk of accidents or injuries
• Social or occupational dysfunction

Lifestyle & Prevention

• Avoid non-medical use of sedative, hypnotic, or anxiolytic drugs
• Use medications only as prescribed and under medical supervision
• Seek help for substance use concerns early
• Maintain open communication with healthcare providers about medication use
• Address underlying mental health conditions to reduce reliance on these substances

When to Seek Professional Help

Seek professional help if experiencing new or worsening psychotic symptoms, difficulty managing substance use, or if the condition interferes with daily functioning. Immediate medical attention is needed for severe symptoms, such as hallucinations or delusions that pose a risk to self or others.

Tips for Medical Coders

When coding F13.95, ensure the documentation clearly links the sedative, hypnotic, or anxiolytic use to the induced psychotic disorder. The code requires both the unspecified use and the presence of the substance-induced psychotic disorder. Verify that the psychotic symptoms are not better explained by another condition and that the substance use is the direct cause. Accurate documentation of the relationship between the substance use and the psychotic disorder is essential for proper coding.